£22k
vs Jul 2024Active06321509Private limited companyManchester
LUMOPHORE LIMITED
Significant control: Mohammad Farid Khan (50–75%)
From public filings as at 31 Aug 2026; may contain errors or be out of date. Verify at Companies House · Terms
Watch this company
Get an email when Companies House records a change for Lumophore Limited: status, filings, accounts, officers or owners. Free.
Not live yet: alerts start by 15 December 2026. We store your email and this company number only, for these alerts. If alerts don’t launch, we tell you and delete your address. Privacy
Coming soon · product and service lists
What does Lumophore Limited sell?
Registered activity: Research and experimental development on biotechnology (SIC 72110). We’re building product and service lists for UK companies. Get this one when it’s ready.
One email, only about this. If we don’t launch within 60 days we’ll tell you. Privacy
01
Summary
LUMOPHORE LIMITED is an active private limited company (company number 06321509) incorporated on 23 July 2007, registered in Manchester. Its registered activity is research and experimental development on biotechnology (SIC 72110). Latest small accounts cover the period ending 31 July 2025, showing net assets of £22k and cash of £22k, with 1 employee on average. Net assets rose 1653% on the prior period (−£1,402).
Peer position · net assets
By net assets it sits in the upper half of 138 comparable companies in Manchester (median £436, upper quartile £124k).
02
Ownership and control
- Dr. Mohammad Farid Khan
- owns 50–75% of shares
Persons with significant control hold 25% or more of shares or voting rights. Smaller shareholdings are only listed in confirmation-statement documents. Directors and secretaries: see the officers list at Companies House.
03
Key dates
- Incorporated
- 23 July 200719 yrs ago
- Next accounts due
- 30 April 2027in 187 days
- Confirmation statement due
- 6 August 2027in 285 days
Due dates are expected from Companies House filing rules; confirm on the official register before relying on them.
04
Activity
- SIC 72110
- Research and experimental development on biotechnology
- Accounts type
- Total Exemption Full
- Size band
- MicroCompanies Act thresholds
05
Financials
£22k
+997%vs Jul 2024Not reported
1
No changevs Jul 2024| Period end | Net assets | Cash | Debtors | Creditors <1y | Turnover | Profit | Employees |
|---|---|---|---|---|---|---|---|
| 31 July 2025 | £22k | £22k | £15k | £1,787 | — | — | 1 |
| 31 July 2024 | −£1,402 | £1,991 | £20k | £1,397 | — | — | 1 |
Current ratio20.62Current assets ÷ creditors within one year
Cash per employee£22kCash ÷ average employees
Figures as filed in iXBRL accounts at Companies House. "—" means the line was not reported in that filing.
06
Filing and accounts signals
- Net assets above zeroNet assets £21,775 at 31 July 2025
- Net assets up 10% or more on the prior period+1653.1% vs prior period
- Current assets at least 1.5× creditors within one yearCurrent ratio 20.62
- Incorporated five or more years agoIncorporated 23 July 2007
Neutral facts read from the register and filed accounts, each with its evidence. They are not a rating, a prediction or advice, and may be incomplete or out of date. How each signal is derived.
07
Timeline
- Confirmation statement duein 285 days
- Next accounts duein 187 days
- Accounts period endNet assets £22k · small accounts
- Accounts period endNet liabilities £1,402 · small accounts
- Incorporated
08
Similar companies in Manchester
- THERACRYF PHARMA LTDNether Alderley · inc. Oct 2007
- GENEDRIVE PLCManchester · inc. Feb 2007
- APEX MOLECULAR LIMITEDAlderley Edge · inc. May 2008
- ACACIA PHARMA LIMITEDAltrincham · inc. Sept 2006
- INSTIL BIO (UK) LIMITEDMacclesfield · inc. Sept 2008
- SKY MEDICAL TECHNOLOGY LIMITEDDaresbury · inc. Mar 2006
All companies incorporated on 23 July 2007 · in Jul 2007.
09
Reminders for LUMOPHORE LIMITED
Get an email before each filing deadline — accounts and confirmation statement — so nothing is late.